Bassim Haidar is interviewed by the BBC at Davos about philanthropy among the super-rich

https://businessofcannabis.com/safricanna-eyes-explosive-global-growth-following-eu-gmp-certification-milestone/

https://www.forbesmiddleeast.com/lists/top-30-fintech-companies-2023/optasia/

Ahead of rolling out his latest project to tackle financial inclusion, Haidar shares his motivations and future plans with The Africa Report. He touches [...]

Medicinal cannabis is a booming industry. As it becomes a well-known treatment for illnesses as varied as Crohn’s disease, epilepsy, Alzheimer’s, multiple sclerosis and [...]

Bloomberg UK interviews Bassim Haidar about what drew him to investing in South Africa’s medicinal cannabis industry, how demand and the market for SafriCanna’s [...]

Hot on the heels of a major expansion of SafriCanna, Bassim Haidar explains how South Africa can unlock the medicinal cannabis industry. According to [...]

Bassim Haidar spoke to Bloomberg’s Monique Vanek about Optasia’s plans to expand further in Africa and across continents, including how it will drive financial [...]

Sharing his optimism about Africa’s place in the tech world, Haidar tells Business Insider why he believes Africa will be a hub of growth [...]

In the interview with Family Capital's James Williams,  Haidar beats the drum for Africa's cannabis industry and talks about his foray into the cannabis [...]

Optasia has been named in Forbes’ Middle East’s Top 25 Fintech Companies 2022. Founded by Bassim Haidar in 2012, Optasia is a leading vendor [...]